The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 study of nanoliposomal irinotecan in combination with trifluridine/tipiracil in refractory solid tumors.
 
Li-Yuan Bai
Honoraria - CStone Pharmaceuticals; Ipsen; Lilly; Ono Pharmaceutical; Pfizer; SynCoreBio
Consulting or Advisory Role - Bristol-Myers Squibb
 
Nai-Jung Chiang
Consulting or Advisory Role - MSD
Speakers' Bureau - MSD; Ono Pharmaceutical; TTY Biopharm
 
Chih-Hung Hsu
Honoraria - Bristol-Myers Squibb; Merck Sharp & Dohme; Ono Pharmaceutical; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono; MSD; Ono Pharmaceutical; Roche/Genentech
Research Funding - AstraZeneca (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Johnson & Johnson (Inst); Merck Serono (Inst); MSD (Inst); Nucana (Inst); Ono Pharmaceutical (Inst); Roche/Genentech (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Merck Sharp & Dohme; Ono Pharmaceutical; Roche/Genentech
 
Yi-Hsin Liang
No Relationships to Disclose
 
Chang-Fang Chiu
No Relationships to Disclose
 
Ching-Chan Lin
No Relationships to Disclose
 
Kwang-Yu Chang
No Relationships to Disclose
 
Shang-Hung Chen
No Relationships to Disclose
 
Hui-Jen Tsai
Honoraria - Pfizer
Consulting or Advisory Role - Bayer
 
Yu-Ping Lin
Employment - PharmaEngine
Stock and Other Ownership Interests - PharmaEngine
Honoraria - PharmaEngine
Travel, Accommodations, Expenses - PharmaEngine
 
Li-Tzong Chen
Leadership - ScinoPharm
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; CStone Pharmaceuticals; Ipsen; Lilly; MSD; Novartis; Ono Pharmaceutical; SynCoreBio; Taivex Therapeutics
Research Funding - ACT Genomics; Bristol-Myers Squibb; Novartis; Pfizer; Polaris; SynCoreBio; TTY Biopharm
Patents, Royalties, Other Intellectual Property - HuniLife (Taiwan)
 
Chia-Chi Lin
Honoraria - Daiichi Sankyo; Lilly; Novartis; Novartis; Roche
Consulting or Advisory Role - Blueprint Medicines; Boehringer Ingelheim; Daiichi Sankyo; Novartis
Travel, Accommodations, Expenses - BeiGene; Daiichi Sankyo; Daiichi Sankyo; Lilly; Novartis